In last trading session, Aileron Therapeutics Inc (NASDAQ:ALRN) saw 0.13 million shares changing hands with its beta currently measuring 2.25. Company’s recent per share price level of $1.93 trading at -$0.12 or -5.85% at ring of the bell on the day assigns it a market valuation of $41.82M. That closing price of ALRN’s stock is at a discount of -284.46% from its 52-week high price of $7.42 and is indicating a premium of 16.58% from its 52-week low price of $1.61. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.16 million shares which gives us an average trading volume of 95.45K if we extend that period to 3-months.
Aileron Therapeutics Inc (NASDAQ:ALRN) trade information
Upright in the red during last session for losing -5.85%, in the last five days ALRN remained trading in the red while hitting it’s week-highest on Thursday, 01/02/25 when the stock touched $1.93 price level, adding 19.58% to its value on the day. Aileron Therapeutics Inc’s shares saw a change of -16.09% in year-to-date performance and have moved -16.09% in past 5-day. Aileron Therapeutics Inc (NASDAQ:ALRN) showed a performance of -12.27% in past 30-days. Number of shares sold short was 0.23 million shares which calculate 3.47 days to cover the short interests.
Aileron Therapeutics Inc (ALRN) estimates and forecasts
Statistics highlight that Aileron Therapeutics Inc is scoring comparatively higher than the scores of other players of the relevant industry. The company lost -36.93% of value to its shares in past 6 months, showing an annual growth rate of 51.25% while that of industry is 17.00. Apart from that, the company came raising its revenue forecast for fiscal year 2025.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 39.67% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 54.53% while estimates for its earnings growth in next 5 years are of 2.10%.
Aileron Therapeutics Inc (NASDAQ:ALRN)’s Major holders
Insiders are in possession of 0.65% of company’s total shares while institution are holding 28.47 percent of that, with stock having share float percentage of 28.66%. Investors also watch the number of corporate investors in a company very closely, which is 28.47% institutions for Aileron Therapeutics Inc that are currently holding shares of the company. HEXAGON CAPITAL PARTNERS LLC is the top institutional holder at ALRN for having 213.0 shares of worth $591.0. And as of 2024-06-30, it was holding 0.0026 of the company’s outstanding shares.
